المؤلفون: Glaviano, Antonino, Foo, Aaron, S C, Lam, Hiu, Y, Yap, Kenneth, C H, Jacot, William, Jones, Robert, H, Eng, Huiyan, Nair, Madhumathy, G, Makvandi, Pooyan, Geoerger, Birgit, Kulke, Matthew, H, Baird, Richard, D, Prabhu, Jyothi, S, Carbone, Daniela, Pecoraro, Camilla, Teh, Daniel, B L, Sethi, Gautam, Cavalieri, Vincenzo, Lin, Kevin, H, Javidi-Sharifi, Nathalie, R, Toska, Eneda, Davids, Matthew, S, Brown, Jennifer, R, Diana, Patrizia, Stebbing, Justin, Fruman, David, A, Kumar, Alan, P

المساهمون: Università degli studi di Palermo - University of Palermo, National University of Singapore (NUS), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), University of Glasgow, Cardiff University, Istituto Italiano di Tecnologia (IIT), Immunologie des tumeurs et immunothérapie (UMR 1015), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Boston University Boston (BU), Cancer Research UK Cambridge Institute Cambridge, Royaume-Uni (CRUK), University of Cambridge UK (CAM), Università degli studi di Catania = University of Catania (Unict), Dana-Farber Cancer Institute Boston, Harvard Medical School Boston (HMS), Johns Hopkins Bloomberg School of Public Health Baltimore, Johns Hopkins University (JHU), Imperial College London, University of California (UC)

المصدر: ISSN: 1476-4598 ; Molecular Cancer ; https://hal.science/hal-04583150Test ; Molecular Cancer, 2023, 22 (1), pp.138. ⟨10.1186/s12943-023-01827-6⟩.

مصطلحات موضوعية: AKT inhibitors, ATP-competitive mTOR inhibitors, Allosteric mTOR inhibitors, Bi-steric mTOR inhibitors, Cancer, Dual PI3K/mTOR inhibitors, Isoform-specific PI3K inhibitors, PDK1 inhibitors, PI3K/AKT/mTORC pathway, Pan PI3K inhibitors, MESH: Humans, MESH: Phosphatidylinositol 3-Kinases, MESH: Proto-Oncogene Proteins c-akt, MESH: Signal Transduction, MESH: TOR Serine-Threonine Kinases, MESH: Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37596643; hal-04583150; https://hal.science/hal-04583150Test; https://hal.science/hal-04583150/documentTest; https://hal.science/hal-04583150/file/12943_2023_Article_1827.pdfTest; PUBMED: 37596643; PUBMEDCENTRAL: PMC10436543

الإتاحة: https://doi.org/10.1186/s12943-023-01827-6Test
https://hal.science/hal-04583150Test
https://hal.science/hal-04583150/documentTest
https://hal.science/hal-04583150/file/12943_2023_Article_1827.pdfTest

المؤلفون: Arana Echarri, Ainhoa, Struszczak, Lauren, Beresford, Mark, Campbell, John P., Jones, Robert H., Thompson, Dylan, Turner, James E.

وصف الملف: application/pdf

العلاقة: https://orca.cardiff.ac.uk/id/eprint/160410/1/fphys-14-1107070.pdfTest; Arana Echarri, Ainhoa, Struszczak, Lauren, Beresford, Mark, Campbell, John P., Jones, Robert H. https://orca.cardiff.ac.uk/view/cardiffauthors/A007428W.htmlTest orcid:0000-0003-3576-9496 orcid:0000-0003-3576-9496, Thompson, Dylan and Turner, James E. 2023. Immune cell status, cardiorespiratory fitness and body composition among breast cancer survivors and healthy women: a cross sectional study. Frontiers in Physiology 14 , 1107070. 10.3389/fphys.2023.1107070 https://doi.org/10.3389/fphys.2023.1107070Test file https://orca.cardiff.ac.uk/id/eprint/160410/1/fphys-14-1107070.pdfTest

الإتاحة: https://doi.org/10.3389/fphys.2023.1107070Test
https://orca.cardiff.ac.uk/id/eprint/160410Test/
https://orca.cardiff.ac.uk/id/eprint/160410/1/fphys-14-1107070.pdfTest

المؤلفون: Beresford, Mark, Casbard, Angela, Hudson, Zoe, Carucci, Margherita, Ingarfield, Kate, Gee, Julia, Smith, Joanna, Kitson, Terri, Alchami, Fouad, Madden, Tracie-Ann, Hayward, Larrie, Hwang, David, Spensley, Saiqa, Waters, Simon, Wheatley, Duncan, Jones, Robert H.

المساهمون: AstraZeneca

المصدر: BJC Reports ; volume 1, issue 1 ; ISSN 2731-9377

الإتاحة: https://doi.org/10.1038/s44276-023-00016-8Test
https://www.nature.com/articles/s44276-023-00016-8.pdfTest
https://www.nature.com/articles/s44276-023-00016-8Test

المؤلفون: Jones, Robert H.

المصدر: The Future of Sustainability Education at North American Universities ; page 65-74 ; ISBN 9781772126679

الإتاحة: https://doi.org/10.1515/9781772126679-007Test

المؤلفون: Jones, Robert H.

الإتاحة: http://purl.galileo.usg.edu/uga%5FetdTest/jones%5Frobert%5Fh%5F200905%5Fmal

المؤلفون: Howell, Sacha J, Casbard, Angela, Carucci, Margherita, Ingarfield, Kate, Butler, Rachel, Morgan, Sian, Meissner, Magdalena, Bale, Catherine, Bezecny, Pavel, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, de Bruin, Elza C, Schiavon, Gaia, Foxley, Andrew, Jones, Robert H

المصدر: Howell , S J , Casbard , A , Carucci , M , Ingarfield , K , Butler , R , Morgan , S , Meissner , M , Bale , C , Bezecny , P , Moon , S , Twelves , C , Venkitaraman , R , Waters , S , de Bruin , E C , Schiavon , G , Foxley , A & Jones , R H 2022 , ' Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION) : overall survival, updated ....

مصطلحات موضوعية: Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Aromatase Inhibitors/therapeutic use, Breast Neoplasms/drug therapy, Double-Blind Method, Female, Fulvestrant, Humans, Neoplasm Recurrence, Local/pathology, Phosphatidylinositol 3-Kinases/genetics, Progression-Free Survival, Proto-Oncogene Proteins c-akt, Pyrimidines, Pyrroles, Receptor, ErbB-2/metabolism, Receptors, Estrogen/metabolism, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre

العلاقة: https://research.manchester.ac.uk/en/publications/9709b095-c00d-4f89-a76b-ad6abaabc582Test

الإتاحة: https://doi.org/10.1016/S1470-2045Test(22)00284-4
https://research.manchester.ac.uk/en/publications/9709b095-c00d-4f89-a76b-ad6abaabc582Test

المؤلفون: Arana Echarri, Ainhoa, Beresford, Mark, Campbell, John P., Jones, Robert H., Butler, Rachel, Gollob, Kenneth J., Brum, Patricia C., Thompson, Dylan, Turner, James E.

وصف الملف: application/pdf

العلاقة: https://orca.cardiff.ac.uk/id/eprint/139162/1/A%20phenomic%20perspective%20on%20factors%20influencing%20breast%20cancer%20treatment.pdfTest; Arana Echarri, Ainhoa, Beresford, Mark, Campbell, John P., Jones, Robert H. https://orca.cardiff.ac.uk/view/cardiffauthors/A007428W.htmlTest orcid:0000-0003-3576-9496 orcid:0000-0003-3576-9496, Butler, Rachel, Gollob, Kenneth J., Brum, Patricia C., Thompson, Dylan and Turner, James E. 2021. A phenomic perspective on factors influencing breast cancer treatment: integrating aging and lifestyle in blood and tissue biomarker profiling. Frontiers in Immunology 11 , 616188. 10.3389/fimmu.2020.616188 https://doi.org/10.3389/fimmu.2020.616188Test file https://orca.cardiff.ac.uk/id/eprint/139162/1/A%20phenomic%20perspective%20on%20factors%20influencing%20breast%20cancer%20treatment.pdfTest

الإتاحة: https://doi.org/10.3389/fimmu.2020.616188Test
https://orca.cardiff.ac.uk/id/eprint/139162Test/
https://orca.cardiff.ac.uk/id/eprint/139162/1/A%20phenomic%20perspective%20on%20factors%20influencing%20breast%20cancer%20treatment.pdfTest

المؤلفون: Neatrour, Matthew A., Jones, Robert H., Golladay, Stephen W.

المصدر: Journal of Ecology, 2007 Nov 01. 95(6), 1274-1283.

الوصول الحر: https://www.jstor.org/stable/4496079Test

المؤلفون: Stevens, Glen N., Jones, Robert H.

المصدر: The New Phytologist, 2006 Jan 01. 171(1), 127-136.

الوصول الحر: https://www.jstor.org/stable/3694489Test

المؤلفون: Jones, Robert H., Casbard, Angela, Carucci, Margherita, Cox, Catrin, Butler, Rachel, Alchami, Fouad, Madden, Tracie-Ann, Bale, Catherine, Bezecny, Pavel, Joffe, Johnathan, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, Foxley, Andrew, Howell, Sacha J.

وصف الملف: application/pdf

العلاقة: https://orca.cardiff.ac.uk/id/eprint/129669/1/1-s2.0-S1470204519308174-main.pdfTest; Jones, Robert H. https://orca.cardiff.ac.uk/view/cardiffauthors/A007428W.htmlTest orcid:0000-0003-3576-9496 orcid:0000-0003-3576-9496, Casbard, Angela https://orca.cardiff.ac.uk/view/cardiffauthors/A111881N.htmlTest orcid:0000-0001-6241-3052 orcid:0000-0001-6241-3052, Carucci, Margherita https://orca.cardiff.ac.uk/view/cardiffauthors/A2191629X.htmlTest, Cox, Catrin, Butler, Rachel https://orca.cardiff.ac.uk/view/cardiffauthors/A167198T.htmlTest, Alchami, Fouad, Madden, Tracie-Ann https://orca.cardiff.ac.uk/view/cardiffauthors/A001522L.htmlTest orcid:0000-0001-7880-7873 orcid:0000-0001-7880-7873, Bale, Catherine, Bezecny, Pavel, Joffe, Johnathan, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, Foxley, Andrew and Howell, Sacha J. 2020. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial. Lancet Oncology 21 (3) , pp. 345-347. 10.1016/S1470-2045(19)30817-4 https://doi.org/10.1016/S1470-2045%2819%2930817-4Test file https://orca.cardiff.ac.uk/id/eprint/129669/1/1-s2.0-S1470204519308174-main.pdfTest

الإتاحة: https://doi.org/10.1016/S1470-2045Test(19)30817-4
https://orca.cardiff.ac.uk/id/eprint/129669Test/
https://orca.cardiff.ac.uk/id/eprint/129669/1/1-s2.0-S1470204519308174-main.pdfTest